These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prenatal exposure to antidepressants: how safe are they? Steiner M Am J Psychiatry; 2012 Nov; 169(11):1130-2. PubMed ID: 23128917 [No Abstract] [Full Text] [Related]
7. Poor neonatal adaptation in term infant. Fluoxetine toxicity. Kwon P; Lefkowitz W Pediatr Ann; 2008 Mar; 37(3):131-3. PubMed ID: 18411855 [No Abstract] [Full Text] [Related]
8. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923 [TBL] [Abstract][Full Text] [Related]
9. Serotonin syndrome in a breast-fed neonate. Morris R; Matthes J BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25948853 [TBL] [Abstract][Full Text] [Related]
10. Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome. Jordan AE; Jackson GL; Deardorff D; Shivakumar G; McIntire DD; Dashe JS J Matern Fetal Neonatal Med; 2008 Oct; 21(10):745-51. PubMed ID: 19012191 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040 [TBL] [Abstract][Full Text] [Related]
13. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines]. Mejías C; Rodríguez-Pinilla E; Fernández Martín P; Martínez-Frías ML Med Clin (Barc); 2007 Apr; 128(15):584-9. PubMed ID: 17462198 [TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Sanz EJ; De-las-Cuevas C; Kiuru A; Bate A; Edwards R Lancet; 2005 Feb 5-11; 365(9458):482-7. PubMed ID: 15705457 [TBL] [Abstract][Full Text] [Related]
16. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy]. de Moor RA; Mourad L; ter Haar J; Egberts AC Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015 [TBL] [Abstract][Full Text] [Related]
19. Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy. Friedman EH Can J Psychiatry; 2001 May; 46(4):371. PubMed ID: 11387796 [No Abstract] [Full Text] [Related]
20. Use of SSRIs in pregnancy: neonatal implications. Courtney K Nurs Womens Health; 2009 Jun; 13(3):234-8. PubMed ID: 19523137 [No Abstract] [Full Text] [Related] [Next] [New Search]